patritumab
daiichi sankyo
['bcsm', 'patritumab', 'breast']
join ian krop, md, phd as he shares results from the phase 1/2 study of patritumab deruxtecan, a her3-directed antibody-drug conjugate, in patients with her3-expressing metastatic #breastcancer at #asco22 at 1:39pmcst today. #bcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.